Nestle Will get Peanut Allergy Remedy With $2 Billion Aimmune Buyout | Investing Information

By Silke Koltrowitz and Manas Mishra (Reuters) – Nestle pays $2 billion to purchase the remaining stake in Aimmune Therapeutics Inc , gaining full possession of the primary U.S.-approved peanut…